KFDA to cancel 9 product licenses of 5 companies

Published: 2003-11-10 06:56:00

Updated: 2003-11-10 06:56:00

The KFDA announced to cancel the product registration for 9 products manufactured by 5 drug companies including Ahnam's cardiovascular drug due to poor qualities.

The product licence for Samick's herbal preparation, Samick Ickjinoryeongsan Ext. granule (lot No. IOSGDG01, expiry date: July 13,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK